Nonetheless, the definitive association between pathogenic SPRED1 variations and tumor predisposition is complicated by the fact that Legius syndrome is very rare, therefore the amount of available evidence is currently insufficient. The gene discussed is SPRED1; the disease is Legius syndrome.